Ken Griffin’s ProShares UltraShort Health Care RXD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q3
Sell
-235,050
Closed -$22.7M 7684
2016
Q2
$22.7M Buy
235,050
+70,900
+43% +$13.7M 0.03% 694
2016
Q1
$20.1M Sell
164,150
-107,525
-40% -$23.7M 0.03% 740
2015
Q4
$32.9M Sell
271,675
-73,000
-21% -$14.9M 0.04% 573
2015
Q3
$44.5M Sell
344,675
-4,650
-1% -$938K 0.04% 490
2015
Q2
$49.2M Buy
349,325
+290,375
+493% +$57.7M 0.04% 506
2015
Q1
$30.2M Sell
58,950
-5,106
-8% -$1.12M 0.03% 746
2014
Q4
$39.9M Sell
64,056
-12,032
-16% -$3.15M 0.04% 568
2014
Q3
$56.7M Buy
76,088
+14,994
+25% +$4.64M 0.06% 362
2014
Q2
$43.9M Sell
61,094
-10,850
-15% -$3.87M 0.05% 442
2014
Q1
$59.1M Buy
+71,944
New +$27.1M 0.07% 339

Other funds holding RXD

Ken Griffin's RXD Position: Q4 2022 in Review

Ken Griffin sold out of ProShares UltraShort Health Care (RXD) in Q4 2022, closing a stake of 10,802 shares — an estimated $326K sold.

Ken Griffin first reported a position in RXD in Q1 2019 and held it in 6 quarters. The position peaked at $540K in Q1 2020. 3 funds tracked by Wall St. Rank hold RXD as of Q4 2022.

  • Ken Griffin reported no remaining ProShares UltraShort Health Care position as of Q4 2022 after selling out during the quarter.
  • Ken Griffin sold 10,802 ProShares UltraShort Health Care shares in Q4 2022, an estimated $326K.
  • Ken Griffin first reported a position in ProShares UltraShort Health Care in Q1 2019 and held it in 6 quarters.
  • Ken Griffin's ProShares UltraShort Health Care position peaked at $540K in Q1 2020.
  • 3 funds tracked by Wall St. Rank held ProShares UltraShort Health Care as of Q4 2022.

Based on Citadel Advisors's 13F filing for Q4 2022, filed 14 Feb 2023.